EHA 2024 | The key unmet needs in ALL
Anita Rijneveld
• 17 Jun 2024
Anita Rijneveld, MD, Erasmus MC, Rotterdam, Netherlands, discusses the key unmet needs in acute lymphoblastic leukemia (ALL). She highlights the lack of novel treatments for T-ALL, and emphasizes the need for more studies to improve first-line treatments for elderly patients with B-ALL. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
